Showing results (131-140 of 170) with videos related to

Sort By:
Pageof 17
Plos Pathogens|February 29, 2024
The timing of HIV-1 infection of cells that persist on therapy is not strongly influenced by replication competency or cellular tropism of the provirusSarah B Joseph, Melissa-Rose Abrahams, Matthew Moeser, et al.
Journal of Virology|December 26, 2024
The persistent pool of HIV-1-infected cells is formed episodically during untreated infectionOlivia D Council, Lynn Tyers, Matthew Moeser, et al.
Frontiers in Immunology|October 1, 2021
Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial VaginosisAndile Mtshali, James Emmanuel San, Farzana Osman, et al.
BMJ Open|November 27, 2020
Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women: study protocol for the first-in-human CAPRISA 012B phase I clinical trialSharana Mahomed, Nigel Garrett, Quarraisha A Karim, et al.
PLOS Global Public Health|September 11, 2025
Neutralizing antibody responses over time in a demographically and clinically diverse cohort of individuals recovered from SARS-CoV-2 acquisition in Africa: A cohort studyNonhlanhla N Mkhize, Shuying Sue Li, Jiani Hu, et al.
BMJ Open|October 6, 2021
Simplifying TREAtment and Monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load testing to improve HIV outcomesAshley R Bardon, Jienchi Dorward, Yukteshwar Sookrajh, et al.
Medrxiv : the Preprint Server for Health Sciences|May 5, 2025
Neutralizing Antibody Responses After mRNA COVID-19 Booster Vaccination are Unaffected by Parasitemia in a Malaria-Endemic SettingTaraz Samandari, Millicent Achola, Jack N Hutter, et al.
The Journal of Infectious Diseases|August 2, 2025
Plasmodium falciparum Parasitemia Does Not Diminish Neutralizing Antibody Responses After mRNA COVID-19 Booster Vaccination in HIV-infected AdultsTaraz Samandari, Millicent Achola, Jack N Hutter, et al.
Current HIV Research|October 6, 2025
Africa is an Essential Partner in the Research and Development of an HIV VaccineGlenda Gray, Carolyn Williamson, Linda-Gail Bekker, et al.
The Lancet. HIV|March 31, 2023
Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B): a phase 1, dose-escalation, randomised controlled trialSharana Mahomed, Nigel Garrett, Edmund V Capparelli, et al.
Pageof 17